Current news articles are found here.
Prof Kelly Chibale is passionate about improving the treatment outcomes of African patients. Read more about why and how his group is understanding drug metabolism in the African population.
Prof Kelly Chibale, founder and director of H3D, was recently interviewed by Chemistry World on his views on leadership, teamwork and his love for science. Read the full article here
Prof Kelly Chibale published an article in the Medicine Maker on how African Pharma has a promising role in changing the afro-pessimistic sentiment, so that we may begin to attract and retain skilled African scientists.
Prof Kelly Chibale published an article in the Daily Maverick on how the Oxford Vaccine Trial is an opportunity for African scientists to lead, earn respect & credibility, and show that Africans can be at the forefront of clinical trial research.
If You Build It, They Will Come' - Prof Kelly Chibale features in The Medicine Maker for founding the first Drug Discovery and Development Centre (H3D) in Africa. He was also included in the magazine's 2020 Power List. See list here: https://themedicinemaker.com/power-list/2020
20 000 South African women marched to the Union Buildings in Pretoria on this day in 1956 to protest the pass laws which required women of colour to carry a passport during the apartheid era.
We are pleased to advise that the H3D Symposium has been rescheduled for 10-12 March 2021, Spier Conference Centre, Stellenbosch, Cape Town.
To register or for more information, please visit the symposium website. Should you require any assistance with your existing or new registration, please do not hesitate to contact our Secretariat Office on: +27 21 9101913 / firstname.lastname@example.org
We look forward to seeing you in March 2021
The Organising Committee
The African Academy of Sciences (AAS), through its Grand Challenges Africa programme, The Drug Discovery and Development Centre (H3D) at the University of Cape Town (UCT), Medicines for Malaria Venture (MMV) and the Bill and Melinda Gates Foundation (BMGF) came together in 2018 to expand and strengthen the drug discovery community in Africa.
The first cohort of eight drug discovery scientists was successfully awarded in June 2019, after a rigorous selection process.
Interested to be a part of the next phase of support for the drug discovery call 2020? Please apply here through the AAS website.Article credit: AAS. (https://www.aasciences.africa/calls/grand-challenges-africa-round-10-2nd-drug-discovery-call)
H3D's Dr John Woodland discusses repurposing antimalarial drugs, such as chloroquine, as viable treatment options in the fight against COVID-19.